Epidermal growth factor receptor (EGFR) (23), vascular endothelial growth factor (VEGF) (24), and mesenchymal-epithelial transition (c-MET or MET) (25) are among the well-established pathways that play an important role in the biology of CRC. Here, VEGFA is linked to colorectal carcinoma.